Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Conditions:   Viral Infection;   Hematopoietic Stem Cell Transplantation (HSCT);   Primary Immunodeficiency Disorders (PID) Intervention:   Biological: Norovirus -specific T-cell (NST) therapy Sponsor:   Children's National Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 31, 2020 Category: Research Source Type: clinical trials

Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)
Condition:   Acute Gastroenteritis Interventions:   Biological: Low-dose vaccine;   Biological: High-dose vaccine;   Biological: Placebo (containing aluminum);   Biological: Placebo (without aluminum) Sponsor:   Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2020 Category: Research Source Type: clinical trials